Fda Us - Search News

US FDA approves new nasal spray for depression treatment

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

UPI News on MSN · 1d

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

Fortune on MSN · 8h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

Atara, FDA

Hosted on MSN · 1d

US FDA puts clinical hold on Atara's trials for cancer cell therapies

Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell therapies, sending the drug developer's shares down more than 4% in premarket trading.

Business Insider · 21h

Atara Biotherapeutics Faces Strategic Uncertainty Amid FDA Hold and CRL Issues

H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on ATRA stock, giving a Hold rating yesterday.Invest with Confidence:

MarketWatch · 1d

Atara's New Drug Applications Placed on Hold by FDA

Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its Ebvallo and ATA3219 programs due to compliance issues at a third-party manufacturing facility.

11h

Trump Orders CDC, FDA, and Other Health Agencies to Go Dark

The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

BusinessMirror21h

US FDA removes coconut from food allergen list–PCA

The exclusion of coconut as a major food allergen eases trade barriers for coconut-based products in the US market, according to the Philippine Coconut Authority (PCA). This, after the US Food and ...

cnbctv1821h

Laurus Labs' US arm gets Form 483 from FDA after 'adverse experience' probe

The inspection focused on the subsidiary's practices and procedures related to Laurus Labs’ marketed products worldwide.

US FDA approves Amgen's colorectal cancer therapy

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

ABC78d

Nutrition labels may come to front of food packages under FDA proposal

WASHINGTON -- The US Food and Drug Administration is proposing that nutrition information be placed on the front of packaged foods to provide at-a-glance information about saturated fat ...

1don MSN

Trump officials pause health agencies’ communications, citing review

The agencies are charged with making decisions that touch the lives of every American and are the source of crucial ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results